pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Fluarix
drug
save

Fluarix

Marketedupdated 3mo ago
by GlaxoSmithKline Consumer Healthcare LP
Approved
community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying Fluarix

  • phase3Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Korea Infantsactive not recruitingn=245
  • phase3Immunogenicity Trial of 3 Influenza Vaccinescompletedn=366
  • phase3A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Agecompletedn=40,817
  • phase4A Study to Assess the Safety and Immune Response of Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) in Participants Aged 65 Years and Older in Indiacompletedn=250
  • phase2A Study to Evaluate the Safety and Immunogenicity of Seasonal Influenza Vaccine and an Adenovirus Serotype 26- Based Vaccine Encoding for the Respiratory Syncytial Virus Pre-fusion F Protein (Ad26.RSV.preF), With and Without Co-administration, in Adults Aged 60 Years and Older in Stable Healthcompletedn=180
  • phase3A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Oldercompletedn=22,502
  • phase2Immunogenicity and Safety of the Concomitant Administration of OVX836 and Quadrivalent Influenza Vaccine in Healthy Volunteers.completedn=180
  • phase3A Study of mRNA-1010 Seasonal Influenza Vaccine in Adultscompletedn=6,102
more trials →

News(0)

no news has mentioned this drug yet

brand
Fluarix
indication
Influenza A Virus, H1N1 Subtype Infections
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 2h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?